M. Jourdan, D. Vos, J. Mechti, N. Klein, and B. , Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1, Cell Death and Differentiation, vol.7, issue.12, p.1244, 2000.
DOI : 10.1038/sj.cdd.4400758
URL : https://hal.archives-ouvertes.fr/inserm-00130981

P. Gomez-bougie, R. Bataille, and M. Amiot, The imbalance between Bim and, 2004.

B. Klein, X. Zhang, Z. Lu, and R. Bataille, Interleukin-6 in human multiple myeloma, Blood, vol.85, p.863, 1995.

O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto, Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma, Nature, vol.332, p.83, 1988.

M. Bataille and R. , Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6, Blood, vol.73, p.517, 1989.

A. Zallone and P. Marchisio, Role of bone marrow stromal cells in the growth of human multiple myeloma, Blood, vol.77, p.2688, 1991.

P. Maraninchi, D. Piechaczyk, M. Bataille, R. Klein, and B. , In vivo interleukin-6 gene expression in the tumoral environment in multiple myeloma Autocrine, Eur J Immunol, vol.21, issue.10, p.1759, 1991.

X. Zhang, J. Gaillard, N. Robillard, Z. Lu, Z. Gu et al., 6 production and highly malignant multiple myeloma: relation with resistance to druginduced apoptosis, Blood, vol.97, pp.483-494

R. Bataille and B. Klein, Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma, Blood, vol.83, pp.3654-3666, 1989.

M. Jourdan, X. Zhang, M. Portier, J. Boiron, R. Bataille et al., IFNalpha induced autocrine production of IL-6 in myeloma cell lines, J Immunol, vol.147, issue.15, p.4402, 1991.

M. Jourdan, J. Veyrune, D. Vos, J. Redal, N. Couderc et al., A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells, Oncogene, vol.22, issue.19, p.2950, 2003.
DOI : 10.1038/sj.onc.1206423
URL : https://hal.archives-ouvertes.fr/inserm-00130855

M. Collins, J. Marvel, P. Malde, and A. Lopez-rivas, Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents, Journal of Experimental Medicine, vol.176, issue.4, p.1043, 1992.
DOI : 10.1084/jem.176.4.1043
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119402/pdf

M. Helle, L. Boeise, and L. Aarden, Functional discrimination between interleukin 6 and interleukin 1, European Journal of Immunology, vol.138, issue.10, p.1535, 1988.
DOI : 10.1002/eji.1830181010

G. Brenning, The in vitro effect of leucocyte ??-interferon on human myeloma cells in a semisolid agar culture system, Scandinavian Journal of Haematology, vol.61, issue.suppl 97, p.178, 1985.
DOI : 10.1111/j.1600-0609.1985.tb01568.x

J. Westendorf, H. Jernberg-wiklund, M. Pettersson, M. Carlsson, and K. Nilsson, Differential human multiple myeloma cell line responsiveness to interferon-alpha Analysis of transcription factor activation and interleukin 6 receptor expression Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells, J Clin Invest Leukemia J Immunol, vol.99, issue.154, pp.447310-234091, 1992.

B. Klein, M. Jourdan, D. Vos, J. Hertogh, C. Fiol et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, 2000.

B. Klein, An inhibitor of the EGF receptor family blocks myeloma cell growth HAL author manuscript inserm-00130868, 2004.